Meeting
2017 ASCO Annual Meeting
Association of SDF1 inhibition with local control and relative cerebral blood volume of glioblastoma.
Authors
Reena Parada Thomas
Stanford University Hospital, Palo Alto, CA
Reena Parada Thomas , Seema Nagpal , Michael Iv , Scott G. Soltys , Cathy Kahn Recht , Sophie Bertrand , Sherif Mark Makar , Zachary Corbin , Kseniya Mandic , Gwen Coffey , Shanika Pelpola , Isabel P Prado , Martin Brown , Lawrence David Recht
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 35, 2017 (suppl; abstr 2058)
DOI
10.1200/JCO.2017.35.15_suppl.2058
Abstract #
2058
Poster Bd #
300
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
A phase I study of chemo-radiotherapy with plerixafor for newly diagnosed glioblastoma (GB).
First Author: Reena Parada Thomas
Poster
2024 ASCO Annual Meeting
A phase II study of plerixafor combined with whole brain radiation therapy (WBRT) for patients with newly diagnosed glioblastoma.
First Author: Toni Cao
Poster
2014 ASCO Annual Meeting
Expression profile of angiogenic factors in paired initial and recurrent glioblastoma.
First Author: Emeline Tabouret
Poster
2022 ASCO Annual Meeting
Bortezomib sensitization of recurrent glioblastoma with unmethylated MGMT promoter to temozolomide, a phase II study (NCT03643549).
First Author: Dorota Goplen